CT Financial Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | $6.38K | Hold |
1,035
| – | – | ﹤0.01% | 488 |
|
|
2016
Q4 | $6.07K | Hold |
1,035
| – | – | ﹤0.01% | 493 |
|
|
2016
Q3 | $5.5K | Hold |
1,035
| – | – | ﹤0.01% | 496 |
|
|
2016
Q2 | $6.85K | Hold |
1,035
| – | – | ﹤0.01% | 473 |
|
|
2016
Q1 | $4.83K | Hold |
1,035
| – | – | ﹤0.01% | 512 |
|
|
2015
Q4 | $5.23K | Hold |
1,035
| – | – | ﹤0.01% | 511 |
|
|
2015
Q3 | $3.64K | Hold |
1,035
| – | – | ﹤0.01% | 544 |
|
|
2015
Q2 | $10.3K | Sell |
1,035
-800
| -44% | -$7.98K | 0.01% | 469 |
|
|
2015
Q1 | $23.4K | Hold |
1,835
| – | – | 0.01% | 373 |
|
|
2014
Q4 | $26K | Buy |
+1,835
| New | +$26K | 0.02% | 296 |
|
|
2014
Q1 | $23.4K | Buy |
+1,835
| New | +$23.4K | 0.01% | 373 |
|